Mechanisms of Organ Specificity in Chemical Carcinogenesis

References

• Rice J M, Frith C H. The nature of organspecificity in chemical carcinogenesis. Organ and Species Specificity in Chemical Carcinogenesis, R Langenbach, S Nesnow, J M Rice. Plenum Press, New York 1983; 1–22
   Google Scholar
• IARC. Some Aromatic Amines, Hydrazine and Related Substances, N-Nitroso Compounds, and Miscellaneous Alkylating Agents. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, IARC, Lyons 1974; Vol. 4
   Google Scholar
• Williams G M, Weisburger J H. Chemical carcinogens. Cassarett andDoull's Toxicology, 3rd ed, C Klaassen, M O Amdur, J. Doull. Macmillan, New York 1986; 99–173
   Google Scholar
• Druckrey H, Preussmann R, Ivankovic S, et al. Organotrope carcinogene Wirkungun bei 65 verschiedenen N-Nitroso-Verbindugen on BD-Ratten. Z Krebsforsch 1967; 69: 103–201
   PubMedGoogle Scholar
• Wogan G N, Paglialunga S, Newberne P M. Carcinogenic effects of low dietary levels of aflatoxin B in rats. Food Cosmet Toxicol 1974; 12: 681–685
   PubMedGoogle Scholar
• Butler W H. Aflatoxicosis in laboratory animals. Aflatoxin, Scientific Background, Control and Implications, L Goldbbatt. Academic Press, New York 1969; 223–236
   Google Scholar
• Herrold K M. Aflatoxin induced lesions in Syrian hamsters. Br J Cancer 1969; 23: 655–660
   PubMed Web of Science ®Google Scholar
• Soderman J V. CRC Handbook of Identified Carcinogens and Noncarcinogens, Vol. 2, Target Organ File. CRC Press, Boca Raton, FL 1982
   Google Scholar
• Druckrey H, Landschütz C, Preussmann R. Oesophagus-carcinome nach inhalation von Methyl-butylnitrosamin (MBNA) an Ratten. Z Krebsforsch 1968; 71: 135–139
   Google Scholar
• Druckrey H, Preussman R, Ivankovic S. N-Nitro compounds in organotropic and transplacental carcinogenesis. Ann NY Acad Sci 1969; 163: 679–696
   Google Scholar
• Druckrey H. Organospecific carcinogenesis in the digestive tract. Topics in Chemical Carcinogenesis, W. Nakahara. University of Tokyo Press, Tokyo 1972; 73–103
   Google Scholar
• Lijinsky W. Carcinogenic and mutagenic N-nitroso compounds. Chemical Mutagens, A Hollander. Plenum Press, New York-London 1976; Vol. 1: 193–217
   Google Scholar
• Pan S C. Chemical carcinogenesis. Tumor, S C Pan. People's Health Publishing House, Beijing 1983; 10–211
   Google Scholar
• Mattoni C, Lefemine G. Carcinogenicity bioassays of vinyl chloride: Current results. Ann N Y Acad Sci 1975; 246: 195–218
   PubMed Web of Science ®Google Scholar
• Miller E C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential address. Cancer Res 1978; 38: 1479–1496
   PubMed Web of Science ®Google Scholar
• Rerup C C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970; 22: 485–518
   PubMedGoogle Scholar
• Tjalve H, Wilander E, Johansson E B. Distribution of labeled streptozotocin in mice: uptake and retention in pancreatic isletes. J Endocrinol 1976; 69: 455–456
   PubMed Web of Science ®Google Scholar
• Rakieten N, Gordon B S, Beaty A, et al. Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc Soc Exp Biol Med 1971; 137: 280–283
   PubMed Web of Science ®Google Scholar
• Magee P N. Toxic liver injury. The metabolism of dimethylnitrosamine. Biochem J 1956; 64: 676–682
   PubMed Web of Science ®Google Scholar
• Magee P N. Organ specificity of chemical carcinogens. Advances in Medical Oncology, Vol. 1, Carcinogenesis, G P Margison. Pergamon Press, Oxford, New York 1978; 213–221
   Google Scholar
• Kleihues P, Patzschke K. Verteilung von N-[14C]methyl-N-nitroharnstoff in der Ratte nach systemischer applikation. Z Krebsforsch 1971; 75: 193–200
   PubMedGoogle Scholar
• Lijinsky W, Garcia H, Keefer L, et al. Carcinogenesis and alkylation of rat liver nucleic acids by nitrosomethylurea and nitrosoethylurea administered by intraportal injection. Cancer Res 1972; 32: 893–897
   PubMed Web of Science ®Google Scholar
• Mueller G C, Miller J A. The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. J Biol Chem 1948; 176: 535–544
   PubMed Web of Science ®Google Scholar
• Conney A H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 1982; 42: 4875–4917
   PubMed Web of Science ®Google Scholar
• Guengerich F P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988; 48: 2946–2954
   PubMed Web of Science ®Google Scholar
• Patten C J, Ning S M, Lu A YH, et al. Acetone-inducible cytochrome P-450: purification, catalytic activity, and interaction with cytochrome b5. Arch Biochem Biophys 1986; 251: 629–638
   PubMed Web of Science ®Google Scholar
• Dong Z, Hong J, Ma Q, et al. Mechanism of induction of cytochrome P-450ac(P-450j) in chemically induced and spontaneously diabetic rats. Arch Biochem Biophys 1988; 263: 29–35
   PubMed Web of Science ®Google Scholar
• Hammons G J, Guengerich F P, Weis C C, et al. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res 1985; 45: 3578–3585
   PubMed Web of Science ®Google Scholar
• Archer M C, Silinskas K C, Zucker P F. Mechanism of organ specificity in nitrosamine carcinogenesis. Adv Exp Med Biol 1986; 197: 1005–1011
   PubMedGoogle Scholar
• Yang C S, Yityoong Y, Hong J, et al. Metabolism of nitrosamines by P-450 isozymes. N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer. IARC, Lyon 1985, IARC Scientific Publication No. 57.
   Google Scholar
• Koenigsmann M, Schmerold I, Jeltsch W, et al. Organ and cell specificity of DNA methylation by N-nitrosomethylamylamine in rats. Cancer Res 1988; 48: 5482–5486
   PubMed Web of Science ®Google Scholar
• Chung S J, Li M H. A comparative study on mutagenesis of methylbenzylnitrosamine in V79 cells co-cultivated with liver or esophageal epithelial cells from chickens, rats and humans. Carcinogenesis 1985; 6: 1731–1734
   PubMed Web of Science ®Google Scholar
• Lin P, Tang C, Frank N, et al. Metabolism of and DNA-methylation by N-nitrosomethylbenzylamine in chicken. Chinese Oncol J 1986; 73–76, (Suppl)
   Google Scholar
• Guengerich F P, Liebler D C. Enzymatic activation of chemicals to toxic metabolites. CRC Crit Rev Toxicol 1987; 14: 259–306
   Google Scholar
• Kadlubar F F, Anson J F, Dooley K L, et al. Formation of urothelial and hepatic DNA adducts from the carcinogen 2-naphthylamine. Carcinogenesis 1981; 2: 467–470
   PubMed Web of Science ®Google Scholar
• Kadlubar F F, Miller J A, Miller E C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxyarylamines in relation to urinary bladder carcinogenesis. Cancer Res 1977; 37: 805–814
   PubMed Web of Science ®Google Scholar
• Frei E, Bertram B, Wiessler M. Glutathione inhibits the alkylation of liver DNA by N-nitrosodimethylamine. Naturwissenschaften 1983; 70: 42–43
   PubMed Web of Science ®Google Scholar
• Jeffery A M. DNA modification by chemical carcinogens. Mechanisms of Cell Transformation by Carcinogenic Agents, D Grunberger, S Goff. Pergamon, New York 1987; 33–71
   Google Scholar
• Weinstein I B. Chemical carcinogenesis. Medical Oncology, P Schien. Macmillan, New York 1985; 63–81
   Google Scholar
• Swenberg J A, Dyroff M C, Bedell M A, et al. 04-Ethyldeoxythymidine, but not O-6 ethyldeoxyguanosine, accumulates in hepatocyte DNA of rats exposed continuously to diethylnitrosamine. Proc Natl Acad Sci (USA) 1984; 81: 1692–1695
   PubMed Web of Science ®Google Scholar
• Denda A, Mori Y, Uchida K, et al. 4-Hydroxyaminoquinoline 1-oxide metabolism and DNA adducts in the early stage of tumorigenesis in rats: Comparison of target organ pancrease with non-target organ liver. Chem Biol Interact 1985; 56: 125–143
   PubMed Web of Science ®Google Scholar
• Swenberg J A, Richardson F C, Boucheron J A. Relationships between DNA adduct formation and carcinogenesis. Environ Health Perspect 1985; 62: 177–183
   PubMed Web of Science ®Google Scholar
• Bedell M A, Lewis J A, Billings K C, et al. Cell specificity in hepatocarcinogenesis: preferential accumulation of O6-methylguanine in target cell DNA during continuous exposure of rats to 1,2-dimethylhydrazine. Cancer Res 1982; 42: 3079–3083
   PubMed Web of Science ®Google Scholar
• Kasai H, Nishimura S, Kuroskawa Y, et al. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 1987; 8: 1959–1961
   PubMed Web of Science ®Google Scholar
• Stowers S J, Anderson M W. Formation and persistence of benzo[a]pyrene metabolite-DNA adducts. Environ Health Perspect 1985; 62: 31–39
   PubMed Web of Science ®Google Scholar
• Neumann H G. Role of extent of persistence of DNA modifications in chemical carcinogenesis by aromatic amines. Rec Res Cancer Res 1983; 84: 77–89
   PubMedGoogle Scholar
• Beland F A, Dooley K L, Jackson C D. Persistence of DNA adducts in rat liver and kidney after multiple doses of carcinogen N-hydroxy-2-acetylaminofluorene. Cancer Res 1982; 45: 1348–1354
   Google Scholar
• Magee P N. Introduction: DNA damage and repair. Organ and Species Specificity in Chemical Carcinogenesis, R Langenbach, S Nesnow, J M Rice. Plenum Press, New York and London 1983; 497–508
   Google Scholar
• Saffhill R, Margison G P, O'Connor P J. Mechanisms of carcinogenesis induced by alkylating agents. Biochim Biophys Acta 1985; 823: 111–145
   PubMed Web of Science ®Google Scholar
• Pegg A E, Dolan M E, Scicchitano D. Studies of the repair of O6-alkylthymine and O4-alkylthymine in DNA by alkyltransferase from mammalian cells and bacteria. Environ Health Perspect 1985; 62: 109–114
   PubMed Web of Science ®Google Scholar
• Muller R, Rajewsky M F. Elimination of O6-ethylguanine from the DNA of brain, liver, and other rat tissues exposured to ethylnitrosourea at different stage of prenatal development. Cancer Res 1983; 43: 2897–2904
   PubMed Web of Science ®Google Scholar
• Lijinsky W. Structure-activity relations in carcinogenesis by N-nitroso compounds. Cancer Metastasis Rev 1987; 6: 301–356
   PubMed Web of Science ®Google Scholar
• Lijinsky W, Singer G M, Kovatch R M. Similar carcinogenic effect in rats of 1-ethyl-l-nitroso-3-hydroxyethylurea and 1-hydroxyethyl-1-nitroso-3-ethylurea. Carcinogenesis 1985; 6: 641–643
   PubMed Web of Science ®Google Scholar
• Tsuda H, Lee G, Farber E. Introduction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogenesis. Cancer Res 1980; 40: 1157–1164
   PubMed Web of Science ®Google Scholar
• Pitot H C. Fundamentals of Oncology. Marcel Dekker, New York 1986; 139–162; 295–322
   Google Scholar
• Laerum O D. The process of carcinogenesis: Target cell properties influencing the risk of malignant transformation. Theories of Carcinogenesis, O H Iversen. Hemisphere Publishing Corporation, New York 1988; 237–285
   Google Scholar
• Sachs L. Regulation of membrane changes, differentiation, and malignancy in carcinogenesis. Harvey Lect 1974; 68: 1–35
   PubMedGoogle Scholar
• Tsuda H, Farber E. Resistant hepatocytes as early changes in liver induced by polycyclic aromatic hydrocarbons. Int J Cancer 1980; 25: 137–139
   PubMed Web of Science ®Google Scholar
• Kleihues P, Magee P N, Austoker J, et al. Reaction of N-methyl-N-nitrourea with DNA of neuronal and glial cells in vivo. FEBS Letters 1973; 32: 105–108
   PubMed Web of Science ®Google Scholar
• Barrett J C, Wiseman R W. Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. Environ Health Perspect 1987; 76: 65–70
   PubMed Web of Science ®Google Scholar
• Neumann H G. The role of DNA damage in chemical carcinogen-sis of aromatic amines. J Cancer Res Clin Oncol 1986; 112: 100–106
   PubMed Web of Science ®Google Scholar
• Hilpert D, Neumann H G. The effects of partial hepatectomy and of promoters on macromolecular binding of trans-4-acerylaminostilbene metabolites in liver and some extrahepatic tissues of rats. Carcinogenesis 1983; 4: 1527–1533
   PubMedGoogle Scholar
• Weinstein I B. The origins of human cancer:molecular mechanisms of carcinogenesis and their implication for cancer prevention and treatment—Twenty-seventh G.H.A. Clowes Memorial Award Lecture. Cancer Res 1988; 48: 4135–4143
   PubMed Web of Science ®Google Scholar
• Bishop J M. Viral oncogenes. Cell 1985; 42: 23–28
   PubMed Web of Science ®Google Scholar
• Weinstein I B. Growth factors, oncogenes, and multistage carcinogenesis. J Cell Biochem 1987; 33: 213–224
   PubMed Web of Science ®Google Scholar
• Stowers S J, Maronpot R R, Reynolds S H. The role of oncogenes in chemical carcinogenesis. Environ Health Perspect 1987; 75: 81–86
   PubMed Web of Science ®Google Scholar
• Topal M D. DNA repair, oncogenes and carcinogenesis. Carcinogensis 1988; 9: 691–696
   PubMed Web of Science ®Google Scholar
• Zarbl H, Sukumar S, Arthur A V, et al. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitrosomethylurea during initiation of mammary carcinogenesis in rats. Nature 1985; 315: 382–385
   PubMed Web of Science ®Google Scholar
• Sukumar S. Involvement of oncogenes in carcinogenesis. Cellular and Molecular Biology of Mammary Cancer, D Medina, W Kidwell, Y Hepprar, E Anderson. Plenum Press, New York 1987; 381–408
   Google Scholar
• Pegg A E. Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest 1984; 2: 223–231
   PubMed Web of Science ®Google Scholar
• Jurnak F. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins. Science 1985; 230: 32–36
   PubMed Web of Science ®Google Scholar
• McCormick F, Clark B F, la Vour T F, et al. A model for the tertiary structure of p21, the product of the ras oncogene. Science 1985; 230: 78–82
   PubMed Web of Science ®Google Scholar
• McCormick F, Levenson C, Cole G, . Genetic and biochemical analysis of ras p21 structure. Critical Molecular Determinants of Carcinogenesis, F F Becker, T J Slaga, et al. University of Texas Press, Austin 1987; 137–142
   Google Scholar
• Dandekar S, Sukumar S, Zarbl H, et al. Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors. Mol Cell Biol 1986; 6: 4104–4108
   PubMed Web of Science ®Google Scholar
• Quintanilla M, Brown K, Ramsden M, et al. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986; 322: 78–80
   PubMed Web of Science ®Google Scholar
• Quaife C J, Pinkert C A, Ornitz D M, et al. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 1987; 48: 1023–1034
   PubMed Web of Science ®Google Scholar
• Adams J M, Harris A W, Pinkert C A, et al. The c-myc oncogene driven by immunoglobulin enhancer induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533–538
   PubMed Web of Science ®Google Scholar
• Hanahan D. Heritable formation of pancreatic B-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985; 315: 115–122
   PubMed Web of Science ®Google Scholar
• Beringer R R, Peschon J J, Messing A, et al. Heart and bone tumors in transgenic mice. Proc Natl Acad Sci (USA) 1988; 85: 2648–2652
   PubMed Web of Science ®Google Scholar
• Ruff E L, Feensta A, Leaders K, et al. Intracisternal A-particle genes as movable elements in the mouse genome. Proc Natl Acad Sci (USA) 1983; 80: 1992–1996
   PubMed Web of Science ®Google Scholar
• Gattoni-Celli S, Hsiao W L, Weinstein I B. Rearranged c-mos locus in a MOPC-21 murine myeloma cell line and its persistence in hybridomas. Nature 1983; 306: 795–796
   PubMed Web of Science ®Google Scholar
• Kirschmerier P, Gattoni-Celli S, Dina D, et al. Carcinogen and radiation transformed C3H 10T1/2 cells contain RNA's homologous to the long terminal repeat sequences of a murine leukemia virus. Proc Natl Acad Sci (USA) 1982; 79: 2773–2777
   PubMed Web of Science ®Google Scholar
• Hsieh L L, Hsiao W-L, Peraino C, et al. Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine. Cancer Res 1987; 47: 3421–3424
   PubMed Web of Science ®Google Scholar
• Guillem J G, Hsieh L L, O'Toole K M, et al. Changes in expression of oncogenes and endogenous retroviral-like sequences during colon carcinogenesis. Cancer Res 1988; 48: 3964–3971
   PubMed Web of Science ®Google Scholar
• Cohen J B, Levinson A D. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 1988; 334: 119–124
   PubMed Web of Science ®Google Scholar
• Andres A C, Schoenenberger C A, Groner B, et al. Ha-ras oncogene expression directed by milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci (USA) 1987; 84: 1299–1303
   PubMed Web of Science ®Google Scholar
• Davis L G, Hennighausen L, Woychik R, . Breast cancer as a heritable trait in transgenic mice. Accomplishments in Cancer Research 1986, J A Former, et al. JB Lippincott Co., Philadelphia 1987; 110–118
   Google Scholar
• Sinn E, Muller W, Pattengale P, et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987; 49: 465–475
   PubMed Web of Science ®Google Scholar
• Jaenisch R. Transgenic animals. Science 1988; 240: 1468–1474
   PubMed Web of Science ®Google Scholar